Application of Individualized Treatment for CLL: Novel Agents, Combinations, and Sequencing Therapy

Learn from the experts about novel agents combinations and sequencing therapy for individualized treatment of patients with CLL. Read a ClinicalThought commentary authored by expert faculty and download the clinical resource and slides. Listen to a podcast for answers to FAQs asked during the live Webinar.

Share

Program Content

Activities

CLL: Personalizing 1L Tx
My Take on Personalizing First-line Treatment for Patients With CLL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 22, 2020

Expires: October 21, 2021

Activities

Treating R/R CLL
Considerations in Selecting Therapy for Previously Treated CLL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

Frontline Therapy for CLL
Optimal Selection of Therapy for Treatment-Naive CLL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2020

Expires: December 02, 2021

Future Directions in CLL
Near Future Directions: Promising Agents and Combinations Under Investigation
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

<i>EP</i>: Personalized Tx in CLL
ExpressPoints Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

Activities

CLL Clinician Resource
Current Treatment Algorithm for CLL and Clinical Trial Spotlight: A Resource for Clinicians
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 04, 2020

Expires: December 03, 2021

Activities

FAQ: Personalizing CLL Tx
Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: December 23, 2020

Expires: December 22, 2021

Provided by

ProCE Banner

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

Supporters

Supported by educational grants from

AstraZeneca Pharmacyclics AbbVie

Janssen administered by Scientific Affairs

Lilly